Find Research Projects

Search results

• Active

  A Phase 2, Long-Term Extension (LTE) Study with Elsubrutinib and Upadacitinib Given Alone or in Combination (ABBV-599) in Subjects with Moderately to Severely Active Systemic Lupus Erythematosus Who Have Completed the M19-130 Phase 2 Randomized Controlled Trial (RCT)

  Hoi, A.

  19/10/21 → 18/10/26

  Project: Research

• Vortex Temporary Percutaneous Transvalvular Circulatory Support System Feasibility Study

  Walton, T.

  18/10/21 → 18/10/23

  Project: Research

• Atmo bar : Development of Atmo Cereal bars

  Gibson, P., Muir, J., Yao, C. & So, D.

  18/10/21 → 17/10/22

  Project: Research

• Citarum Transformation: A Living Laboratory for International Research and Impact

  Ramirez, D., Raven, R., Wong, T., Holden, J., Suwarso, R., Marthanty, D. R., Zurbrügg, C., Hardesty, B. D. & Endyana, C.

  15/10/21 → 14/10/22

  Project: Research

• TALAPRO-3: A PHASE 3, RANDOMIZED, DOUBLE-BLIND, STUDY OF TALAZOPARIB WITH ENZALUTAMIDE VERSUS PLACEBO WITH ENZALUTAMIDE IN MEN WITH DDR GENE MUTATED METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER

  Frydenberg, M. & Lai, L. H.

  13/10/21 → 31/12/24

  Project: Research

• A first-in-human (FIH), multicentre, open-label, Phase 1 dose escalation study to evaluate the safety, tolerability and pharmacokinetics of YH004 as a single agent and YH004 in combination with Toripalimab (Anti-PD-1 mAb) in subjects with advanced solid tumors and relapsed or refractory non-hodgkin lymphoma

  Hamid, A. & Lai, L. H.

  13/10/21 → 31/12/24

  Project: Research

• A multicenter, open-label extension study to assess the long-term safety, tolerability, and efficacy of bimekizumab in the treatment of subjects with active psoriatic arthritis

  Antony, A.

  12/10/21 → 11/10/26

  Project: Research

• Development of stimuli responsive RAFT polymers for controlling froth stability

  Ritchie, C., Franks, G. V., Peng, Y. & Ata, S.

  11/10/21 → 31/12/26

  Project: Research

• A Randomized, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of Vedolizumab Intravenous as Maintenance Therapy in Pediatric Subjects with Moderately to Severely Active Crohn’s Disease Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy

  Moore, G.

  8/10/21 → 7/10/26

  Project: Research

• Projects to Platforms: Investigating New Forms of Collaboration—Scoping Study (Building 4.0 CRC, Project 3)

  Maxwell, D., Sohal, A., Nand, A., Moehler, R., Singh, P. J., Samson , D., Chen , L. & Seyedghorban, Z.

  8/10/21 → 7/10/22

  Project: Research

• CHAMPION-AF: WATCHMAN FLX versus NOAC for EMbolic ProtectION in the Management of Patients with Non-Valvular Atrial Fibrillation

  Alison, J.

  8/10/21 → 7/10/26

  Project: Research

• Pharmacodynamics of Pre-Operative PD1 CheckpOint Blockade and Receptor Activator of NF-κB Ligand (RANKL) Inhibition in Non-Small Cell Lung Cancer (NSCLC) – a phase 1B/2 trial

  Ahern, E.

  6/10/21 → 5/10/26

  Project: Research

• The PRELUDE Study

  Sparrow, M. & McKenzie, J.

  4/10/21 → 31/12/24

  Project: Research

• A DOUBLE-BLIND, PLACEBO-CONTROLLED, STUDY TO EVALUATE THE EFFICACY AND SAFETY OF 24 WEEKS TREATMENT WITH REN001 IN PATIENTS WITH PRIMARY MITOCHONDRIAL MYOPATHY (PMM)

  Thyagarajan, D. & Wilson-Lee, P.

  4/10/21 → 31/12/24

  Project: Research

• Functional Lung Imaging in the Assessment of Severe Lung Disease for Lung Transplantation: FIT Study

  Snell, G., Westall, G., Whitford, H., Levin, K., Crowhurst, T., Vazirani, J., Kotecha, S. & Levvey, B.

  4/10/21 → 31/12/24

  Project: Research

• New Vehicle Evaluation: VW Crafter, Toyota RAV4 Hybrid, Toyota Kluger Hybrid, Mitsubishi Outlander PHEV

  Logan, D.

  Ambulance Victoria (AV) (Victoria)

  1/10/21 → 31/12/21

  Project: Research

• Equity Trustees Medical Research and Health Partner Program

  Teede, H.

  1/10/21 → 30/09/24

  Project: Research

• Neck weakness prevalence in motor neuron disease

  Morgan, P.

  1/10/21 → 31/12/21

  Project: Research

• Foetal microchimerism: a potential mechanism for long-term pregnancy effects on disability and epigenetic age in multiple sclerosis

  Zhong, M. L. X., Jokubaitis, V. & Campagna, M. P.

  1/10/21 → 30/09/22

  Project: Research

• Microfibrillated protein fibres

  Barrow, C., Height, M., Patti, A. & Little, K.

  1/10/21 → 14/12/24

  Project: Research

• Bridge and Bridge Tech Fellowship

  Murthi, P.

  1/10/21 → 1/10/22

  Project: Research

• Epigenetic regulation of genomic stability and inheritance

  Western, P., Blewitt, M. & Ritchie, M. E.

  1/10/21 → 30/09/24

  Project: Research

• Reversing post-traumatic epilepsy

  Casillas-Espinosa, P., O'Brien, T., Shah, A., Anderson, A., Huang, E., Shultz, S., Jones, N. & Schittenhelm, R.

  30/09/21 → 30/09/24

  Project: Research

• Measuring inflammation in brain and blood for predicting risk of post-traumatic epilepsy

  Ali, I., Jones, N., O'Brien, T., Dedeurwaerdere, S., Wright, D. & Vivash, L.

  United States Department of Defense (DOD)

  30/09/21 → 30/09/24

  Project: Research

• A multi-center open-label, phase I/II clinical trial to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of ICP-192 in patients with advanced solid tumors and FGFR gene alterations

  Ahern, E.

  30/09/21 → 29/09/26

  Project: Research

• A randomised, double-blind, placebo controlled, first-in-human study to investigate the safety, tolerability, and pharmacokinetic and pharmacodynamic response of SLN360 in subjects with elevated lipoprotein(a)

  Nicholls, S.

  30/09/21 → 29/09/26

  Project: Research

• A Randomised, Double-Blinded, Placebo-Controlled, Multicenter, Phase II Study to Evaluate Senaparib Maintenance in mCRPC Patients with Homologous Recombination Repair Gene Alterations after Docetaxel Treatment

  Pook, D. & Lai, L. H.

  29/09/21 → 31/12/24

  Project: Research

• A Multicenter, Open label, Phase III Extension Trial to Study the Long-term Safety and Efficacy in Participants with Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab Trial

  Strickland, A.

  28/09/21 → 27/09/26

  Project: Research

• A Phase I, First-in-Human, Multicentre, Open-label Study of RC118 for Injection in Patients with Locally Advanced Unresectable/Metastatic Solid Tumours

  Richardson, G. & Lai, L. H.

  27/09/21 → 31/12/24

  Project: Research

• ARC Training Centre in Optimisation Technologies, Integrated Methodologies, and Applications (OPTIMA)

  Smith-Miles, K., Stuckey, P., Taylor, P. G., Ernst, A., Aickelin, U., Garcia De La Banda, M., Pearce, A., Wallace, M., Bondell, H., Hyndman, R., Alpcan, T., Thomas, D. A., Anjomshoa, H., Kirley, M. G., Tack, G., Costa, A., Fackrell, M., Zhang, L., Glazebrook, K., Branke, J., O'Sullivan, B., O'Shea, N., Cheah, A., Meehan, A., Wetenhall, P., Bowly, D., Bridge, J., Faka, S., Mareels, I., Coleman, R. A. & Crook, J.

  23/09/21 → 23/09/26

  Project: Research

• Cryo‐EM structure determination of G protein‐coupled receptors

  Sexton, P., Wootten, D., Belousoff, M., Nar, H., Weichert, D., Ebenhoch, R., Ou, Q. & Lee, D.

  21/09/21 → 21/09/25

  Project: Research

• An evaluation of the efficacy of eptinezumab in the inpatient management of status migrainosus in comparison to intravenous lignocaine in patients who have failed other therapies

  Hutton, E.

  21/09/21 → 31/12/23

  Project: Research

• Research Report on Maritime People Smuggling in South and South East Asia

  Bird, L. & Hedwards, B.

  MBIE - Ministry of Business, Innovation and Employment (New Zealand)

  20/09/21 → 28/02/22

  Project: Research

• A Phase 3, Multicenter, Open-Label, Long-Term Trial to Evaluate the Safety and Efficacy of Efgartigimod (ARGX 113) PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia

  Kaplan, Z.

  20/09/21 → 19/09/26

  Project: Research

• Delivery of an online professional learning program: Differentiated Instruction - Accommodating Diverse Student Profiles

  Subban, P.

  20/09/21 → 29/10/21

  Project: Consultancy

• A first-in-human, Phase I/II, open-label study to evaluate the safety, tolerability, pharmacokinetics and preliminary antitumour activity of EMB-06 in patients with recurrent or refractory multiple myeloma

  Kenealy, M. & Lai, L. H.

  20/09/21 → 31/12/24

  Project: Research

• Phase 2 study evaluating the efficacy and safety of biomarker-driven therapies in patients with persistent or recurrent rare epithelial ovarian tumours [WO42178] [BOUQUET]

  Richardson, G. & Lai, L. H.

  15/09/21 → 31/12/27

  Project: Research

• Development of a new type of vaccine to prevent stomach cancer

  Ferrero, R.

  15/09/21 → 14/09/24

  Project: Research

• A Phase 3 Randomized Study Comparing Bortezomib, Lenalidomide and Dexamethasone (VRd) followed by Ciltacabtagene Autoleucel, a Chimeric Antigen Receptor T cell (CAR-T) Therapy Directed Against BCMA versus Bortezomib, Lenalidomide, and Dexamethasone (VRd) followed by Lenalidomide and Dexamethasone (Rd) Therapy in Participants with Newly Diagnosed Multiple Myeloma for Whom Hematopoietic Stem Cell Transplant is Not Planned as Initial Therapy

  Spencer, A. & Kennedy, N.

  15/09/21 → 31/12/24

  Project: Research

• Mechanism of secretion of large clostridial toxins

  Lyras, D., McGowan, S. & Awad, M.

  Australian Research Council (ARC)

  14/09/21 → 13/09/24

  Project: Research

• Science Monograph Series - Integrated Science Learning in STEM

  Berry, A. & Smith, K.

  14/09/21 → 28/02/22

  Project: Research

• An Adaptive, Open-Label, Dose-Finding, Phase 1/2 Study Investigating the Safety, Pharmacokinetics, and Clinical Activity of PRN1008, an Oral BTK Inhibitor, in Patients with Relapsed Immune Thrombocytopenia

  Kaplan, Z.

  14/09/21 → 13/09/26

  Project: Research

• A Phase 1 Multi-Country, Multi-Center, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of SHR-A1811 in HER2 Expressing or Mutated Advanced Malignant Solid Tumor Subjects

  Voskoboynik, M.

  13/09/21 → 31/12/24

  Project: Research

• Catch.com.au Forecasting Project

  Bergmeir, C. & Pan, S.

  10/09/21 → 3/12/21

  Project: Research

• A Phase 1a/1b Dose Escalation and Dose Expansion, First-in-human, Open-Labeled Study of the Safety,Pharmacokinetics, and Pharmacodynamics of ETH-155008, A Dual Inhibitor of CDK4/6 and Pim, in Subjects with Relapsed or Refractory B-cell NHL, CLL/SLL and AML

  Patil, S. & Kennedy, N.

  9/09/21 → 31/12/24

  Project: Research

• Efficacy and safety investigation of NNC0194-0499 co-administered with semaglutide in subjects with non-alcoholic steatohepatitis: a dose-ranging, placebo-controlled trial

  Roberts, S.

  9/09/21 → 31/12/24

  Project: Research

• A Phase 1b/2, Open-label, Global, Multicenter, Dose Determination, Dose Expansion Study to Evaluate Safety, Tolerability, and Preliminary Efficacy of CC-486 (ONUREG®) in Combination Therapy in Subjects with Acute Myeloid Leukemia (AML)

  Wei, A. & Kennedy, N.

  9/09/21 → 31/12/25

  Project: Research

• A Multicenter, Single-Arm Prospective Study to Evaluate Safety and Efficacy of GLE/PIB 8-Week Treatment in Adults and Adolescents with Acute Hepatitis C Virus (HCV) Infection

  Doyle, J. & Roney, J. J.

  9/09/21 → 31/12/25

  Project: Research

• Interface-aware numerical methods for stochastic inverse problems

  Droniou, J., Cui, T., Badia, S., Marzouk, Y. & Carrera, J.

  8/09/21 → 8/09/24

  Project: Research

• A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of AL002 in Participants with Early Alzheimer's Disease

  O'Brien, T.

  7/09/21 → 31/12/24

  Project: Research